WATSON 3219 (Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg)

Pill imprint WATSON 3219 has been identified as Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg.

Aspirin/butalbital/caffeine is used in the treatment of migraine; pain; headache and belongs to the drug class analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine 325 mg / 50 mg / 40 mg has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.

See also related documents.

Images for WATSON 3219 (Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg)

Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine
Imprint:
WATSON
3219
Strength:
325 mg / 50 mg / 40 mg
Color:
Green & Yellow
Size:
29.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3219
Inactive Ingredients:
microcrystalline cellulose
corn starch
magnesium silicate
D&C Yellow No. 10
FD&C Green No. 3
gelatin
ferric oxide red

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)